[Tyr0] – Neurokinin CAS NO.116868-93-0

[Tyr0] – Neurokinin CAS NO.116868-93-0

[Tyr0] – Neurokinin CAS NO.116868-93-0

[Tyr0] – Neurokinin CAS NO.116868-93-0

[Tyr0] – Neurokinin CAS NO.116868-93-0

[Tyr0] – Neurokinin (CAS NO. 116868-93-0) is a synthetic, N-terminally extended analog of the endogenous neuropeptide Substance P (Neurokinin P). This research-grade peptide features an additional tyrosine residue at the N-terminus (position 0), which facilitates radiolabeling with iodine-125 (¹²⁵I) for sensitive detection and binding assays.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
[Tyr⁰]-Neurokinin
CAS NO.
116868-93-0
Appearance
White to off-white lyophilized powder
Molecular Formula
C59H89N15O16S
Molecular Weight
 1296.52/mol 
Purity (RP-HPLC)
≥98%
Solubility

Soluble in water (≥1 mg/mL), 0.1% TFA in water, or dilute acetic acid

Endotoxin≤1.0 EU/mg
Biological Activity
This peptide segment is a prohormone region of ANF and does not exhibit direct vasoactive activity.
Storage Conditions
Store at ≤ -20°C in a dry, dark environment.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

This peptide functions as a high-affinity agonist for tachykinin receptors, particularly the neurokinin 1 (NK1) receptor. The addition of the tyrosine residue does not significantly alter its core receptor-binding domain or biological activity. Upon binding to NK1 receptors, which are predominantly expressed in the central and peripheral nervous systems, it activates Gq protein-coupled signaling. 


2.PRODUCT INDICATIONS

This product is indicated for advanced research in neuropharmacology, receptor biology, and signal transduction. Its primary applications include: radioligand binding assays (after iodination with ¹²⁵I) for studying NK1 receptor density and pharmacology, investigating tachykinin receptor-mediated functions in pain, inflammation, and emesis, serving as a standard or agonist control in functional assays (e.g., calcium flux), and exploring the role of Substance P in neurological and inflammatory disorders.


3.CLINICAL EFFICACY OF PRODUCT

[Tyr0] – Neurokinin is a vital research probe, not a therapeutic. Its "efficacy" is defined by its utility in fundamental and translational science. As a key radioligand precursor, it has been indispensable for mapping NK1 receptor distribution in tissues and characterizing novel NK1 receptor antagonists. This foundational research directly enabled the development of clinical drug candidates targeting the NK1 receptor for conditions such as chemotherapy-induced nausea and vomiting (e.g., aprepitant), depression, and chronic pain.


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.